NCT06480760View on ClinicalTrials.gov

Effects of Carnosine In Patients With Peripheral Arterial Disease Patients

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

144

Participants

Timeline

Start Date

May 20, 2025

Primary Completion Date

October 1, 2028

Study Completion Date

October 1, 2028

Conditions
Peripheral Arterial Disease
Interventions
DRUG

Carnosine

Food ingredient (supplement)

Trial Locations (3)

40202

RECRUITING

University of Louisville School of Medicine, Department of Medicine, Division of Environmental Medicine, Louisville

NOT_YET_RECRUITING

University Surgical Associates, 401 E. Chestnut St, Suite 710, Louisville

NOT_YET_RECRUITING

UofL Physicians - Vascular Surgery Associates, 201 Abraham Flexner Way, Suite 1004, Louisville

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Shahid Baba

OTHER